Sign In
Buy PCB
$24.00
-0.520 (-2.12%)
At Close: Jun 03, 2026
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
02:16pm, Wednesday, 06'th Apr 2022 Benzinga
Upgrades
According to Morgan Stanley, the prior rating for Royalty Pharma PLC (NASDAQ:RPRX) was changed from Equal-Weight to Overweight. In the fourth quarter, Royalty Pharma showed an EPS of $0.80, c
Carlyle (CG) Boosts Global Credit Arm With Fortitude Re Deal
01:19pm, Friday, 01'st Apr 2022 Zacks Investment Research
Carlyle's (CG) new advisory agreement with reinsurer Fortitude Re is set to boost its fee-earnings assets under management by $50 billion.
Carlyle (CG) Rides on Organic Growth, Rising Expenses Ail
05:10pm, Monday, 28'th Mar 2022 Zacks Investment Research
Carlyle's (CG) organic growth, backed by increasing AUM balance and fund management fees, is a positive. Yet, a rise in expenses and competition for investment opportunities are concerning.
Federated Hermes (FHI) Strategic Buyouts Aid, Cost Woes Stay
02:18pm, Tuesday, 22'nd Mar 2022 Zacks Investment Research
Federated Hermes' (FHI) efforts to expand via acquisitions and operational expansion efforts are commendable. Yet, higher expenses and a strict regulatory environment are major drags.
Deutsche Bank (DB) to Withdraw From Russia, Sets '25 Goals
04:54pm, Monday, 14'th Mar 2022 Zacks Investment Research
Deutsche Bank (DB) announces its financial plans and capital distribution strategy to be carried out by 2025 while winding down its business in Russia.
PCB Bancorp: 2.65% Dividend And Virtually No Non-Performing Assets
10:00am, Monday, 14'th Mar 2022
In excess of 60% of PCB Bancorp's loan book is invested in commercial real estate loans.
Citi's (C) Sale of Russian Consumer Bank Arm Delayed Amid War
06:29pm, Thursday, 10'th Mar 2022 Zacks Investment Research
There will likely be a snag in Citi's (C) sale of its consumer banking unit in Russia on grounds of the escalated geopolitical tension surrounding the country's conflict with Ukraine.
Should Investors Fret Over UBS Group's (UBS) Russian Exposure?
05:45pm, Wednesday, 09'th Mar 2022 Zacks Investment Research
UBS Group (UBS) reveals its $634-million exposure to Russia that has subsided since 2021 end.
Here's Why You Should Hold Fifth Third (FITB) Stock for Now
09:13pm, Tuesday, 08'th Mar 2022 Zacks Investment Research
Fifth Third's (FITB) sound diversified revenue sources, rising loan and deposit balances and strong liquidity bode well. Rising costs, margin pressure and a concentrated loan portfolio are woes.
Comerica (CMA) Deepens Focus on Growth: Time to Buy the Stock?
10:33pm, Friday, 04'th Mar 2022 Zacks Investment Research
Comerica (CMA) is tailormade for your portfolio on the back of its revenue-driving moves and solid organic growth story.
Franklin (BEN) Rides on Strategic Buyouts, Higher Costs Ail
04:32pm, Friday, 04'th Mar 2022 Zacks Investment Research
Franklin's (BEN) efforts to expand via acquisitions and strong diversification strategies are commendable. Yet, higher expenses and a strict regulatory environment are major drags.
Citi (C) to Launch Citi Alliance - A Banking & Lending Program
10:39pm, Thursday, 03'rd Mar 2022 Zacks Investment Research
Citi (C) to unveil a premium banking and lending program by this summer to fulfill the untapped requirements of the independent advisory industry.
Citigroup (C) Projects Revenue & Expense Growth for 2022
04:27pm, Thursday, 03'rd Mar 2022 Zacks Investment Research
Higher interest rates, modest loan and deposit growth, and higher fees are expected to drive Citigroup's (C) revenue growth in 2022.
Should Investors Fret Over Citi's (C) $9.8B Russian Exposure?
11:25pm, Wednesday, 02'nd Mar 2022 Zacks Investment Research
Given its strong fundamentals, Citi's (C) disclosure of its approximate $10-billion exposure to Russia is not likely to affect its financials.
UBS Group (UBS) to Spruce Up Wealth Unit for the Affluent
11:06pm, Wednesday, 02'nd Mar 2022 Zacks Investment Research
UBS Group (UBS) will create a new business unit to serve the super-rich by bringing together several services catering to the elite demographic.
